All News

How One Organization is Helping People Navigate the ‘Pain, Confusion and Chaos’ of a Cancer Diagnosis

February 23rd 2021, 10:00pm

Article

A cancer diagnosis often comes with concerns of what’s next for patients. One concern is how they’re going to afford their treatments. Here, a panel of experts discuss what options are available.

Shattering Myths: How Patients With Cancer Can Become Better Health Advocates

February 23rd 2021, 7:00pm

Article

There are two myths that patients with cancer believe when it comes to being health advocates. Here, a panel of experts look to dispel those myths to help patients become better advocates.

After Weighing the Pros and Cons of Getting a COVID-19 Vaccine, I Decided to Get One

February 23rd 2021, 5:00pm

Article

A cancer survivor reflects on her decision to receive a COVID-19 vaccine when it was made available to her.

‘WhatsApp’ Text Message Reminder Improves Adherence to Long-Term Screening for Colorectal Cancer

February 23rd 2021, 4:00pm

Article

Sending a text message reminder to participants about their upcoming fecal immunochemical test improved previously poor adherence rates for colorectal cancer screening.

Immunotherapy Combinations Offer ‘Hope and Promise’ for Patients with Advanced Renal Cell Carcinoma

February 23rd 2021, 2:00pm

Video

Positive results from the phase 3 CLEAR clinical trial, presented at the 2021 ASCO Genitourinary Cancers Symposium, are just one more dataset that could offer “a sense of hope and promise” for patients with advanced renal cell carcinoma (RCC), says the study’s lead author, Dr. Robert J. Motzer.

Cancer Survivors, Patients Share Their Favorite Motivational or Inspirational Quote

February 22nd 2021, 8:30pm

Article

On social media, CURE® recently asked its readers to share their favorite motivational or inspirational quotes. Here's what they had to share.

FDA Approves Front-Line Libtayo for Advanced Non-Small Cell Lung Cancer Subset

February 22nd 2021, 6:41pm

Article

The Food and Drug Administration has approved first-line Libtayo (cemiplimab-rwlc) monotherapy for patients with advanced non-small cell lung cancer with a PD-L1 expression of 50% or greater.

Make Room For The Under-65s: What the COVID-19 Vaccine Rollout Has Taught Me About My 'Value'

February 22nd 2021, 5:00pm

Article

Vaccine eligibility forces this metastatic breast cancer patient to confront the value society places on her life.

Fear of Recurrence: Identify Risks, Learn to Cope

February 22nd 2021, 4:00pm

Article

There are certain patient characteristics that are associated with fear of recurrence. However, there are simple steps that survivors can take to cope.

Knocking Out Chronic Myeloid Leukemia with Precision

February 22nd 2021, 2:00pm

Article

Patients with chronic myeloid leukemia are living longer, some even stopping treatment, thanks to a plethora of targeted therapies.